Regeneron Pharmaceuticals, Inc. Class Action: The Gross Law Firm Reminds Regeneron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN
Portfolio Pulse from
The Gross Law Firm has issued a notice to shareholders of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) regarding a pending class action lawsuit. Shareholders who purchased shares during the specified class period are encouraged to consider lead plaintiff appointment, with a deadline of March 10, 2025.
January 20, 2025 | 11:00 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a class action lawsuit, and shareholders are encouraged to consider lead plaintiff roles by March 10, 2025.
The announcement of a class action lawsuit can negatively impact investor sentiment and potentially lead to a decline in stock price. The legal proceedings may introduce uncertainty and risk, affecting short-term stock performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100